ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

IMCR Immunocore Holdings PLC

53.29
-0.96 (-1.77%)
시간외 거래
최종 업데이트: 06:30:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Immunocore Holdings PLC IMCR 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.96 -1.77% 53.29 06:30:00
개장가 저가 고가 종가 전일 종가
54.62 53.195 55.07 53.29 54.25
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/05/202420:13EDGAR2Form 8-K - Current report
08/05/202420:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202420:00GLOBEImmunocore reports first quarter financial results and..
24/04/202423:00GLOBEImmunocore announces upcoming presentation and posters at..
05/04/202405:00GLOBEImmunocore to present at upcoming investor conferences
06/03/202406:30GLOBEImmunocore presented two posters at CROI 2024
01/03/202421:00GLOBEImmunocore to present at upcoming investor conferences
29/02/202406:19EDGAR2Form 8-K - Current report
29/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202421:34GLOBEImmunocore reports fourth quarter and full year 2023..
28/02/202421:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202408:46EDGAR2Form 144 - Report of proposed sale of securities
22/02/202421:00GLOBEImmunocore announces clinical trial collaboration and supply..
22/02/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202421:00GLOBEImmunocore to report fourth quarter and full year 2023..
03/02/202406:05EDGAR2Form 8-K - Current report
31/01/202413:30GLOBEImmunocore Prices Upsized Convertible Senior Notes Offering
30/01/202407:06EDGAR2Form 8-K - Current report
30/01/202406:05GLOBEImmunocore Announces Proposed Convertible Senior Notes..
06/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202421:19EDGAR2Form 8-K - Current report
05/01/202421:00GLOBEImmunocore announces strategic priorities and pipeline..
04/01/202407:55EDGAR2Form 144 - Report of proposed sale of securities
03/01/202421:00GLOBEImmunocore to present at the 42nd Annual J.P. Morgan..
03/01/202406:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/01/202420:25EDGAR2Form 8-K - Current report
28/12/202307:30EDGAR2Form 144 - Report of proposed sale of securities
21/12/202303:54EDGAR2Form 144 - Report of proposed sale of securities
01/12/202310:33EDGAR2Form 144 - Report of proposed sale of securities
30/11/202318:00GLOBELevicept Appoints Eliot Forster as CEO
16/11/202323:51EDGAR2Form 144 - Report of proposed sale of securities
07/11/202321:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202321:00GLOBEImmunocore Reports Third Quarter 2023 Financial Results and..
07/11/202309:20EDGAR2Form 144 - Report of proposed sale of securities
02/11/202305:01GLOBEImmunocore announces upcoming poster presentations at SITC..
31/10/202305:30GLOBEImmunocore to present at upcoming investor conferences
21/10/202321:45GLOBEImmunocore presents three-year overall survival data from..
06/10/202320:01GLOBEImmunocore announces upcoming presentation and posters at..
03/10/202305:31EDGAR2Form 144 - Report of proposed sale of securities
12/09/202306:00GLOBEImmunocore to present at upcoming investor conferences
02/09/202305:00GLOBEImmunocore to present at upcoming investor conferences
26/08/202307:10EDGAR2Form 144 - Report of proposed sale of securities
18/08/202304:44EDGAR2Form 144 - Report of proposed sale of securities
10/08/202321:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/08/202320:00GLOBEImmunocore Reports Second Quarter 2023 Financial Results and..
03/08/202321:00GLOBEImmunocore to report second quarter 2023 financial results..
15/07/202305:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..